Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/SHILPAMED stock hub

NSE/SHILPAMED has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/SHILPAMEDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

85.3B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/SHILPAMED

In the news

Latest news · NSE/SHILPAMED

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E24.1

P25 24.9P50 32.4P75 45.7

Trailing P/E56.9

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC6.9

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/SHILPAMED market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

195

Groups with data

Currency

INR

Showing 195 of 195 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	998
Employees Change	-9%
Employees Change Percent	-0.89
Enterprise value	INR 91B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE790G01031
Last refreshed	2026-05-10
Market cap	INR 85.3B
Price	INR 434
Price currency	INR
Rev Per Employee	14,363,303.61x
Sector	Healthcare
Sic	2833
Symbol	nse/SHILPAMED
Website	https://www.vbshilpa.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.76%
EV Earnings	60.68x
EV/EBIT	34.27x
EV/EBITDA	23.93x
EV/Sales	6.35x
Forward P/E	24.12x
P/B ratio	3.5x
P/E ratio	56.87x
P/S ratio	5.95x
PE Ratio10 Y	65.25x
PE Ratio3 Y	83.75x
PE Ratio5 Y	108.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.46%
EBITDA Margin	26.4%
Gross margin	67.45%
Gross Profit	INR 9.7B
Gross Profit Growth	19.4%
Gross Profit Growth Q	21.06%
Gross Profit Growth3 Y	14.73%
Gross Profit Growth5 Y	10.68%
Net Income	INR 1.5B
Net Income Growth	69.95%
Net Income Growth Q	40.27%
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Net Income Growth3 Y	208.4%
Net Income Growth5 Y	-2.91%
Pretax Margin	13.26%
Profit Margin	10.47%
Profit Per Employee	INR 1.5M
Profitable Years	2
Roa5y	2.47
Roe5y	3.6
ROIC	6.94
Roic5y	2.96

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	6.34%
Cagr15y	17.31%
Cagr1y	38.14%
Cagr3y	49.37%
Cagr5y	14.6%
Div CAGR10	6.16%
Div CAGR3	-3.13%
Div CAGR5	-13.79%
EPS Growth	121.8
EPS Growth Q	45.23
EPS Growth Quarters	3
EPS Growth Years	2
EPS Growth3 Y	227.7
EPS Growth5 Y	-0.64
Revenue Growth	14.79x
Revenue Growth Q	28.31x
Revenue Growth Quarters	10x
Revenue Growth Years	2x
Revenue Growth3 Y	8.3x
Revenue Growth5 Y	9.43x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 219.7M
Debt	INR 5.9B
Debt EBITDA	INR 1.56
Debt Equity	INR 0.24
Equity	INR 24.4B
Interest Coverage	6.17
Net Cash	INR -5.7B
Net Cash By Market Cap	INR -6.7
Net Debt EBITDA	INR 1.51
Net Debt Equity	INR 0.23
Tangible Book Value	INR 18.3B
Tangible Book Value Per Share	INR 93.36
WACC	5.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	23.38%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 0.5
Dividend Years	1
Dividend Yield	0.12%
Ex Div Date	2025-09-17
Last Dividend	INR 0.5

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	84.91%
1Y total return	38.11%
200-day SMA	368.1
3Y total return	233.35%
50-day SMA	370.4
50-day SMA vs 200-day SMA	50over200
5Y total return	97.68%
All Time High	500
All Time High Change	-13.2%
All Time High Date	2025-06-16
All Time Low	22.52
All Time Low Change	1,827.43%
All Time Low Date	2011-12-19
ATR	18.65
Beta	0.14
Ch YTD	35.14
High	447.7
High52	500
High52 Date	2025-06-16
High52ch	-13.2%
Low	432.1
Low52	259.5
Low52 Date	2026-01-27
Low52ch	67.25%
Ma50ch	17.16%
Price vs 200-day SMA	17.89%
RSI	68.44
RSI Monthly	61.68
RSI Weekly	67.86
Sharpe ratio	0.94x
Sortino ratio	1.8
Total Return	23.49%
Tr YTD	35.14
Tr15y	996.91%
Tr1m	10.9%
Tr1w	3.65%
Tr3m	37.39%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 2.6B
Operating Income Growth	37.73
Operating Income Growth Q	61.78
Operating Income Growth3 Y	84.7
Operating Income Growth5 Y	11.91
Operating margin	18.46

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	95,736,468%
Shares Insiders	48.51%
Shares Institutions	16.11%
Shares Qo Q	-3.55%
Shares Yo Y	-23.38%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	513,835x
Bv Per Share	124.4
Ch10y	82.12
Ch15y	963.3
Ch1m	10.9
Ch1w	3.65
Ch1y	37.94
Ch3m	37.39
Ch3y	233
Ch5y	96.49
Ch6m	17.76
Change	-1.74%
Change From Open	-0.91
Close	441.7
Days Gap	-0.84
Depreciation Amortization	1,139,096,250
Dollar Volume	300,579,720
Earnings Date	2026-05-22
EBIT	INR 2.6B
EBITDA	INR 3.8B
EPS	INR 10.33
F Score	2
Fiscal Year End	March
Founded	1,987
Graham Number	145.94498
Graham Upside	-66.37
Income Tax	INR 400.9M
Is Primary Listing	0
Last Earnings Date	2026-02-06
Last Report Date	2025-12-31
Last Split Date	2025-10-03
Last Split Type	Forward
Lynch Fair Value	INR 38.16
Lynch Upside	-91.21
Ma150	347.6
Ma150ch	24.85%
Ma20	417.8
Ma20ch	3.88%
Next Earnings Date	2026-05-22
Open	438
Payment Date	2025-10-23
Position In Range	12.46
Price Date	2026-05-08
Price EBITDA	INR 22.54
Ptbv Ratio	4.67
Relative Volume	1.38x
Revenue	14,334,577,000x
Tax By Revenue	2.8x
Tax Rate	21.09%
Tr6m	17.76%
Volume	692,580

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/SHILPAMED dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.1%

$0.50 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-13.8%

0 consecutive years of growth

Total shareholder yield

+23.5%

Next ex-dividend date: 2025-09-17

Performance

NSE/SHILPAMED stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/SHILPAMED?

Insider, institutional, and short-interest positioning.

Institutional ownership

+16.1%

Share of float held by funds and institutions

Insider ownership

+48.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-23.4%

Negative means the company is buying back shares.

Technical

NSE/SHILPAMED momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

68.4

Neutral momentum band

Price vs 200-day MA

+17.9%

50/200-day relationship not available

Beta (5Y)

0.14

Less volatile than the market

Sharpe ratio

0.94

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/SHILPAMED

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/SHILPAMED stock rating?

nse/SHILPAMED is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/SHILPAMED analysis?

The full report lives at /stocks/nse/SHILPAMED/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/SHILPAMED?

The latest report frames nse/SHILPAMED around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/SHILPAMED page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.